Retinitis pigmentosa is a kind of cortex on retinal pigment degeneration, chronic, progressive visual function, genetic, nutrition is not virtuous, retinal degenerative eye disease, the disease involving the eyes, men more than women, more incidence of 10 to 20 years old, a few people with the disease in the home, the faster progress in the earlier onset, curative effect is poorer, old age comes on slowly.
This report contains market size and forecasts of Retinitis Pigmentosa (Retinitis) in Global, including the following market information:
Global Retinitis Pigmentosa (Retinitis) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Retinitis Pigmentosa (Retinitis) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
General Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Retinitis Pigmentosa (Retinitis) include Sanofi, Amgen, Amarantus Bioscience Holdings, Acucela, Applied Genetic Technologies Corp, Asklepios BioPharmaceutical, Astellas Pharma, Caladrius Biosciences and Dompe Farmaceutici SpA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retinitis Pigmentosa (Retinitis) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinitis Pigmentosa (Retinitis) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Retinitis Pigmentosa (Retinitis) Market Segment Percentages, by Type, 2021 (%)
General Treatment
Traditional Chinese Medicine
Gene Therapy
The Surgical Treatment
Other
Global Retinitis Pigmentosa (Retinitis) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Retinitis Pigmentosa (Retinitis) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Eye Clinics
Other
Global Retinitis Pigmentosa (Retinitis) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Retinitis Pigmentosa (Retinitis) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinitis Pigmentosa (Retinitis) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Retinitis Pigmentosa (Retinitis) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Amgen
Amarantus Bioscience Holdings
Acucela
Applied Genetic Technologies Corp
Asklepios BioPharmaceutical
Astellas Pharma
Caladrius Biosciences
Dompe Farmaceutici SpA
Dormant Projects
GenSight Biologics SA
Grupo Ferrer Internacional SA
ID Pharma
InFlectis BioScience
Ionis Pharmaceuticals
Mimetogen Pharmaceuticals
M's Science Corp
Nanovector srl
Novartis AG
Novelion Therapeutics
ProQR Therapeutics
ReNeuron Group Plc
SanBio
Shire (Takeda Pharmaceutical)
Spark Therapeutics
Sun Pharma Advanced Research Company